Author:
Huang Hung-Che,Chen Heng-Chung,Fang Hsin-Yuan,Lin Yi-Chieh,Wu Chin-Yen,Cheng Ching-Yuan
Abstract
Abstract
Objectives
Most cases of pleural empyema are caused by pulmonary infections, which are usually combined with pneumonia or lung abscess. The mortality of patients with pleural empyema remains high (up to 20%). It also contributes to higher hospital costs and longer hospital stays. We studied pleural empyema with combined lung abscess to determine if abscess was associated with mortality.
Methods
From January 2004 to December 2006, we retrospectively reviewed 259 patients diagnosed with pleural empyema who received thoracscopic decortications of the pleura in a single medical center. We evaluated their clinical data and analyzed their chest computed tomography scans. Outcomes of pleural empyema were compared between groups with and without lung abscess.
Results
Twenty-two pleural empyema patients had lung abscesses. Clinical data showed significantly higher incidences in the lung abscess group of pre-operative leukocytosis, need for an intensive care unit stay and mortality.
Conclusion
Patients with pleural empyema and lung abscess have higher intensive care unit admission rate, higher mortality during 30 days and overall mortality than patients with pleural empyema. The odds ratio of lung abscess is 4.685. Physician shall pay more attention on high risk patient of lung abscess for early detection and management.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,General Medicine,Surgery,Pulmonary and Respiratory Medicine
Reference20 articles.
1. Schopf LF, Fraga JC, Amantea SL, Sanches P, Muller A, Borowski S, Kulczynski J, Costa E: Induction of pleural empyema in rats by thoracentesis with intrapleural pressure monitoring. Pediatric surgery international. 2004, 20: 515-519. 10.1007/s00383-004-1227-2.
2. Jess P, Brynitz S, Friis Moller A: Mortality in thoracic empyema. Scand J Thorac Cardiovasc Surg. 1984, 18: 85-87.
3. Sahn SA: Management of complicated parapneumonic effusions. Am Rev Respir Dis. 1993, 148: 813-817.
4. Bouros D, Plataki M, Antoniou KM: Parapneumonic effusion and empyema: best therapeutic approach. Monaldi Arch Chest Dis. 2001, 56: 144-148.
5. Kunz CR, Jadus MR, Kukes GD, Kramer F, Nguyen VN, Sasse SA: Intrapleural injection of transforming growth factor-beta antibody inhibits pleural fibrosis in empyema. Chest. 2004, 126: 1636-1644. 10.1378/chest.126.5.1636.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献